Cells require the wild‐type MLL1 gene for viability in the presence of a heterozygous MLL1‐fusion gene, as antisense‐dependent knockdown of wild‐type MLL1 reduces tumor growth and angiogenesis in vivo (Ansari et al., 2013). The gene discussed is KMT2A; the disease is neoplasm.